Top Markets
Coin of the day
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Rankning i aktier #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Aktiekurs
$0.03302716
Senast synkroniserad: 2026-08-13
Marknadsvärde
$3.32M
Förändring (1 dag)
0.00%
Förändring (1 år)
-34.80%
Land
CA
Handel Telo Genomics Corp. (TELO)

Kategori

Antal utestående aktier för Telo Genomics Corp. (TELO)
Antal utestående aktier per August 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för Telo Genomics Corp. är det aktuella antalet utestående aktier 0. I slutet av August 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Telo Genomics Corp. (TELO) från 2026 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
Inte tillräckligt med data för de angivna datumen.
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
371.00M -
US
705.30M -
US
- -
CN
143.28M -
US
80.10M -
US